Home » Radiopharmaceutical Theranostics Market

Radiopharmaceutical Theranostics Market By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Radium-223, Fluorine-18) By Application (Oncology, Cardiology, Others) -Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 20088 | Report Format : PDF

Key Highlights of the Report

The radiopharmaceutical theranostics market is segmented by radioisotope, application, source, approach, radiotracer type, end user, and region. The Lutetium-177 segment holds the largest market share under the radioisotope segment, with the North American region leading the market growth. In the application segment, the oncology segment holds the largest revenue share. Cyclotrons, Targeted therapeutic, peptidic, and hospitals are the leading segments in source, approach, radiotracer type, and end-user, respectively.

The Radiopharmaceutical Theranostics Market has several drivers, generating major oncology deals globally, and the rise in incidence and prevalence of target conditions are driving the market growth. However, the market also faces significant challenges, such as the short half-life of radiopharmaceuticals and high equipment prices.

Nonetheless, The Radiopharmaceutical Theranostics Market offers significant growth opportunities; initiatives are significantly increasing to reduce the demand-supply gap.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Overview

Steady growth in recent years is expected to grow at a CAGR of 11.90% between 2022 and 2030. The market was valued at USD 1.6 billion in 2022 and is expected to reach USD 3.52 billion in 2030.

What Are the Main Drivers of The Radiopharmaceutical Theranostics Market?

The Radiopharmaceutical Theranostics Market is driven by several factors, generating major oncology deals globally and a rise in the incidence and prevalence of target conditions. These factors increase the demand for Radiopharmaceutical Theranostics, which drives market growth.

What Are the Major Challenges Faced by The Radiopharmaceutical Theranostics Market?

The Radiopharmaceutical Theranostics Market also faces several, including high equipment prices.

What Are the Growth Opportunities in The Radiopharmaceutical Theranostics Market?

The Radiopharmaceutical Theranostics Market offers significant growth opportunities, and the rise in initiatives to reduce the demand-supply gap presents a significant growth opportunity.

Radiopharmaceutical Theranostics Market

Executive Summary

Overview of The Radiopharmaceutical Theranostics Market

The Radiopharmaceutical Theranostics Market has been steadily growing in recent years, driven by generating major oncology deals globally. The rise in the incidence and prevalence of target conditions has increased the demand for Radiopharmaceutical Theranostics. A wide range of applications and end-user characterizes the market.

The Radiopharmaceutical Theranostics Market refers to the market for specialized pharmaceutical products known as radiopharmaceuticals used for diagnostic and therapeutic purposes.

Radiopharmaceuticals are radioactive compounds that can be administered to patients for imaging purposes to diagnose various diseases, such as cancer and cardiovascular disorders. These compounds emit radiation that can be detected by imaging technologies, such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT), providing valuable information about the physiological and metabolic activities within the patient’s body.

In addition to their diagnostic applications, radiopharmaceuticals can also be used for targeted therapy. By attaching specific radioactive isotopes to pharmaceutical agents, these products can deliver therapeutic radiation directly to diseased tissues, such as tumors, while minimizing damage to surrounding healthy tissues.

The radiopharmaceutical theranostics market encompasses developing, producing, and commercializing radiopharmaceuticals for diagnostic and therapeutic purposes. It involves various stakeholders, including pharmaceutical companies, radiopharmaceutical manufacturers, healthcare providers, research institutions, and regulatory authorities.

Market Insights

  • The global demand for Radiopharmaceutical Theranostics was valued at USD 1.6 billion in 2022 and is anticipated to reach USD 3.52 billion in 2030, growing at a CAGR of 11.90% between 2023 and 2030.
  • Litetium-177 holds the largest market share leading the radioisotopes segment.
  • The oncology application segment is expected to post the highest CAGR during the forecast period between 2022-2030. Cyclotrons, Targeted therapeutic, peptidic, and hospitals are the leading segments in source, approach, radiotracer type, and end-user, respectively.
  • The North American region is fuelling the growth of the Radiopharmaceutical Theranostics Market with a high revenue
  • the
  • rise incidence and prevalence of target conditions are the major drivers of market growth.
  • Challenges due to the short half-life of radiopharmaceuticals and high equipment prices.
  • Major growth opportunities to the Radiopharmaceutical Theranostics Market.

Segmentation by Radioisotope:

  • The Lutetium 177 dominates the market with a significant market share as of 2022.
  • Technetium 99, gallium 68, iodine 131, radium 223, fluorine 18, and yttrium 90 are other radioisotopes.
  • Copper 67 &64, samarium 153, and others hold the rest of the market share.

Segmentation by Application :

  • The oncology segment is accountable for holding the largest market share.
  • The cardiology segment also holds a significant market share after the oncology segment.
  • Other segments hold the rest of the market share.

Segmentation by Source

  • The cyclotrons market has a dominant position with the largest market share.
  • Nuclear reactors also hold a significant market share after cyclotrons.
  • The rise in demand for PET imaging agents is expected to propel the cyclotrons segment.

Segmentation by  Approach

  • The targeted therapeutic segment leads the market with a significant market share.
  • The targeted therapeutic segments grow due to increased demand for personalized cancer treatment.
  • A companion diagnostic is responsible for the rest of the market share.

Segmentation by Radiotracer type

  • The peptidic segment holds a significant market share.
  • The growth of the peptidic segment is because of increased research & development in peptide therapeutics and the development of new imaging and treatment options for neuroendocrine tumors and prostate cancer.
  • Non-peptidic segment holds the rest of the market share.

Segmentation by End-user

  • The hospital segment is accountable for holding the largest market share.
  • The growth of the hospital segment is for factors such as an increase in healthcare spending, a rise in the incidence of cancer, and a surge in the adoption of nuclear medicine and molecular imaging techniques in clinical practice.
  • Academic research institutes and others hold the rest of the market share.

Segmentation by Region :

  • North America region held a significant market share as of 2022, characterized by a high adoption rate of advanced medical technologies
  • The Asia Pacific market is experiencing rapid growth due to increasing healthcare expenditures.
  • latin america The rest of the world, including Latin America,
  • The Middle East, and Africa, contributes the remainder to the demand for Radiopharmaceutical theranostics.

The United States has been dominant in the global Radiopharmaceutical Theranostics market. The U.S. market has seen significant growth and has held a substantial market share in this sector. The United States has a well-established healthcare system, advanced medical infrastructure, and a strong research and development ecosystem. These factors have contributed to the country’s leadership in developing and adopting radiopharmaceuticals for therapeutic and diagnostic purposes. The United States is home to several renowned pharmaceutical companies, research institutions, and academic centers actively advancing radiopharmaceutical therapies. These organizations have made significant investments in research and development, clinical trials, and manufacturing capabilities, contributing to the growth of the market.

China’s large population, increasing incidence of cancer and other diseases, and rising healthcare expenditure contribute to the growing demand for advanced diagnostic and therapeutic solutions such as radiopharmaceutical theranostics. China has made notable progress in the production and distribution of radiopharmaceuticals. The country has been focusing on expanding its capabilities in manufacturing radioisotopes, establishing radiopharmaceutical production facilities, and fostering collaborations between academic institutions, healthcare providers, and industry players.The Chinese government has recognized these technologies’ importance and implemented policies to support their development and adoption. China has thriving biotechnology and pharmaceutical industry provides a strong foundation for the development and commercialization of radiopharmaceutical theranostics.

Radiopharmaceuticals are generating major oncology deals globally:

Radiopharmaceuticals have gained prominence in oncology due to their ability to deliver targeted radiation therapy to cancer cells. Pharmaceutical companies and radiopharmaceutical manufacturers often enter into collaborations or partnerships to develop and commercialize new radiopharmaceutical products. These collaborations leverage the expertise and resources of multiple entities, leading to accelerated product development and market access. Major oncology deals involving radiopharmaceuticals include mergers, acquisitions, or licensing agreements between pharmaceutical companies, manufacturers, and biotechnology firms. Such transactions enable the consolidation of expertise, technologies, and product pipelines, allowing companies to strengthen their market position, expand their product portfolio, and access new markets or technologies. Radiopharmaceuticals offer unique advantages in oncology, such as targeted therapy, accurate imaging, and improved treatment outcomes. As a result, pharmaceutical companies and investors recognize the potential of radiopharmaceutical theranostics and are actively seeking opportunities to enter or expand their presence in this market.

Rise in Incidence and Prevalence of Target Conditions

Cancer is one of the primary target conditions for radiopharmaceutical theranostics. Cancer incidence is rising globally due to an aging population, lifestyle changes, and environmental factors. As cancer rates increase, the demand for effective diagnostic and therapeutic solutions grows. Radiopharmaceuticals play a crucial role in cancer diagnosis, staging, treatment planning, and targeted therapy, making them an essential tool in the management of the disease. The prevalence of cardiovascular diseases is increasing worldwide. Besides cancer, cardiovascular disorders, and neurological disorders, radiopharmaceutical theranostics find applications in various other conditions, such as infectious diseases, inflammatory conditions, and bone disorders. As the prevalence of these conditions increases, there is a corresponding need for accurate and effective diagnostic and therapeutic solutions, driving the demand for radiopharmaceuticals.

Short Half-Life of Radiopharmaceuticals and High Equipment Prices

Radiopharmaceuticals contain radioactive isotopes that decay over time, resulting in a limited effective lifespan known as the half-life. The short half-life of radiopharmaceuticals necessitates efficient production, transportation, and distribution processes to ensure their availability when needed. It also poses logistics, inventory management, and patient scheduling challenges. Healthcare facilities and providers must have appropriate infrastructure and resources to handle radiopharmaceuticals with short half-lives. These considerations can increase operational complexities and costs, potentially limiting market growth. Radiopharmaceutical theranostics rely on advanced imaging technologies, such as PET and SPECT scanners, as well as radioisotope production and dispensing equipment. These specialized equipment and infrastructure come with high upfront costs and maintenance expenses.

Rise in Initiatives to Reduce the Demand-Supply Gap

The demand for radiopharmaceuticals is growing due to their expanding applications in diagnostics and targeted therapies. However, the production and supply of radiopharmaceuticals can face challenges in meeting the increasing demand. Initiatives to reduce the demand-supply gap can focus on increasing production capacities, optimizing manufacturing processes, and improving supply chain logistics. These efforts can ensure a steady and reliable supply of radiopharmaceuticals to meet the rising demand, thereby fostering market growth. Initiatives to reduce the demand-supply gap often involve infrastructure development and capacity expansion in radiopharmaceutical production facilities. This can include investments in new production facilities, upgrading existing manufacturing plants, and enhancing radioisotope production capabilities. By increasing the capacity to produce radiopharmaceuticals, these initiatives can bridge the gap between demand and supply, leading to market growth. The rise in initiatives to reduce the demand-supply gap reflects the growing recognition of the importance of radiopharmaceuticals in healthcare. Ultimately, these initiatives contribute to improved patient care, increased market access, and sustainable growth.

Competitive Landscape

Key Players

The Radiopharmaceutical Theranostics Market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • Bayer AG
  • GE Healthcare Technologies Inc
  • Curium
  • Lantheus Medical Imaging, Inc.
  • Telix Pharmaceuticals Ltd.
  • Cardinal Health Inc
  • Advanced Accelerator Applications S.A.
  • Jubilant Radiopharmacy
  • Theranostics
  • NuView Life Sciences

On March 23, 2022, Novartis announced the U.S. Food and Drug Administration (FDA) approval for Pluvicto for treating  adult patients with a certain type of advanced cancer called prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The Radiopharmaceutical Theranostics Market is segmented by radioisotope, application, source, approach, radiotracer type, end user, and region.
  • Generating major oncology deals globally and the rise in incidence and prevalence of target conditions are the major drivers of market growth.
  • However, the Radiopharmaceutical Theranostics Market faces challenges as a reason for the short half-life of radiopharmaceuticals and high equipment prices.
  • North America region is fuelling the growth of the Radiopharmaceutical Theranostics Market with the highest revenue share .
  • Litetium-177 holds the largest market share leading the radioisotopes segment.The oncology application segment is expected to post the highest CAGR during the forecast period between 2022-2030. Cyclotrons, Targeted therapeutic, peptidic, and hospitals are the leading segments in source, approach, radiotracer type, and end user, respectively.

Future Outlook

  • As the prevalence of cancer continues to increase, the demand for radiopharmaceutical theranostics is expected to grow.
  • Advancements in imaging technology, including the development of more sensitive and specific radiotracers, improved imaging resolution, and hybrid imaging modalities, are driving the growth of radiopharmaceutical theranostics.
  • The increasing adoption of personalized medicine is expected to drive the growth of the radiopharmaceutical theranostics market.
  • There is significant investment in research and development activities focused on radiopharmaceutical theranostics.

Segmentation :

By Radioisotope

  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Radium-223
  • Fluorine-18
  • Yttrium-90
  • Lutetium-177
  • Copper-67 and 64
  • Samarium-153
  • Others

By Application

  • Oncology
  • Cardiology
  • Others

By Source

  • Nuclear Reactors
  • Cyclotrons

My Approach

  • Targeted Therapeutic (Rx)
  • Companion Diagnostic (DX)

By Radiotracer Type

  • Peptidic
  • Non-peptidic

By End-user

  • Hospitals
  • Academic Research Institutes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • The U.K.
    • France
    • Italy
    • Spain
    • The Netherlands
    • Russia
    • Switzerland
    • Poland
    • Sweden
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Singapore
    • Indonesia
    • Taiwan
    • Australia
  • Central & South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • A.E.

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Radiopharmaceutical theranostics Market
2.2. Global Radiopharmaceutical theranostics Market, By Radiosotope
2.3. Global Radiopharmaceutical theranostics Market, By Source
2.4. Global Radiopharmaceutical theranostics Market, By Approach
2.5. Global Radiopharmaceutical theranostics Market, By End-User
2.6. Global Radiopharmaceutical theranostics Market, By Application
2.7. Global Radiopharmaceutical theranostics Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Radiopharmaceutical theranostics Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Radiosotope
3.5.2. Source
3.5.3. Approach
3.5.4. End-User
3.5.5. Application
3.5.6. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Vehicles Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Radiopharmaceutical theranostics Market, By Approach
7.1. Global Radiopharmaceutical theranostics Market Overview, by Approach
7.1.1. Global Radiopharmaceutical theranostics Market Revenue Share, By Approach, 2022 Vs 2030 (in %)
7.2. Targeted Therapeutic (Rx)
7.2.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
7.3. Companion Diagnostic (DX)
7.3.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
7.4. Radiotracer Type
7.4.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
7.5. Peptidic
7.5.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
7.6. Non-peptidic
7.6.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)

8. Global Radiopharmaceutical theranostics Market, By Source

9. Global Radiopharmaceutical theranostics Market Overview, by Source
9.1.1. Global Radiopharmaceutical theranostics Market, By Source, 2022 vs 2030 (in %)
9.2. Nuclear Reactors
9.2.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
9.3. Cyclotrons
9.3.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)

10. Global Radiopharmaceutical theranostics Market, by Application, 2017-2030 (US$ Bn)
10.1. Global Radiopharmaceutical theranostics Market Overview, by Application
10.1.1. Global Radiopharmaceutical theranostics Market, By Application, 2022 vs 2030 (in%)
10.2. Oncology
10.2.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
10.3. Cardiology
10.3.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
10.4. Others
10.4.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)

11. Global Radiopharmaceutical theranostics Market, by End-User, 2017-2030 (US$ Bn)
11.1. Global Radiopharmaceutical theranostics Market Overview, by End-User
11.1.1. Global Radiopharmaceutical theranostics Market, By End-User, 2022 vs 2030 (in%)
11.2. Hospitals
11.2.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
11.3. Academic & Research Institutes
11.3.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
11.4. Others
11.4.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)

12. Global Radiopharmaceutical theranostics Market, by Radiosotope , 2017-2030 (US$ Bn)
12.1. Global Radiopharmaceutical theranostics Market Overview, by Radiosotope
12.1.1. Global Radiopharmaceutical theranostics Market, By Radiosotope, 2022 vs 2030 (in%)
12.2. Technetium-99
12.2.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.3. Gallium-68
12.3.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.4. Iodine-131
12.4.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.5. Radium-223
12.5.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.6. Fluorine-18
12.6.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.7. Yttrium-90
12.7.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.8. Lutetium-177
12.8.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.9. Copper-67 & 64
12.9.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.10. Samarium- 153
12.10.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)
12.11. Others
12.11.1. Global Radiopharmaceutical theranostics Market, By Region, 2017-2030 (US$ Bn)

13. Global Radiopharmaceutical theranostics Market, By Region
13.1. Global Radiopharmaceutical theranostics Market Overview, by Region
13.1.1. Global Radiopharmaceutical theranostics Market, By Region, 2022 vs 2030 (in%)
13.2. Radiosotope
13.2.1. Global Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
13.3. Source
13.3.1. Global Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
13.4. Approach
13.4.1. Global Radiopharmaceutical theranostics Market, By Approach Type, 2017-2030 (US$ Bn)
13.5. End-User
13.5.1. Global Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
13.6. Application
13.6.1. Global Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

14. North America Radiopharmaceutical theranostics Market Analysis
14.1. North America Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. North America Radiopharmaceutical theranostics Market, by Source, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. North America Radiopharmaceutical theranostics Market, by Approach, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. North America Radiopharmaceutical theranostics Market, by End-User, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. North America Radiopharmaceutical theranostics Market, by Application, 2017-2030(US$ Bn)
14.5.1. Overview
14.5.2. SRC Analysis

14.6. North America Radiopharmaceutical theranostics Market, by Country, 2017-2030 (US$ Bn)
14.6.1. North America Radiopharmaceutical theranostics Market, by Country, 2022 Vs 2030 (in%)
14.6.2. U.S.
14.6.2.1. U.S. Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.6.2.2. U.S. Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
14.6.2.3. U.S. Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
14.6.2.4. U.S. Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
14.6.2.5. U.S. Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
14.6.2.6. U.S. Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
14.6.3. Canada
14.6.3.1. Canada Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.6.3.2. Canada Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
14.6.3.3. Canada Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
14.6.3.4. Canada Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
14.6.3.5. Canada Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
14.6.3.6. Canada Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
14.6.4. Mexico
14.6.4.1. Mexico Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.6.4.2. Mexico Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
14.6.4.3. Mexico Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
14.6.4.4. Mexico Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
14.6.4.5. Mexico Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
14.6.4.6. Mexico Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

15. Europe Radiopharmaceutical theranostics Market Analysis
15.1. Europe Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Europe Radiopharmaceutical theranostics Market, by Source, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Europe Radiopharmaceutical theranostics Market, by Approach, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Europe Radiopharmaceutical theranostics Market, by End-User, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Europe Radiopharmaceutical theranostics Market, by Application, 2017-2030(US$ Bn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Europe Radiopharmaceutical theranostics Market, by Country, 2017-2030 (US$ Bn)
15.6.1. Europe Radiopharmaceutical theranostics Market, by Country, 2022 Vs 2030 (in%)
15.6.2. Germany
15.6.2.1. Germany Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.2.2. Germany Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.2.3. Germany Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.2.4. Germany Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.2.5. Germany Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.2.6. Germany Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

15.6.3. France
15.6.3.1. France Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.3.2. France Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.3.3. France Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.3.4. France Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.3.5. France Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.3.6. France Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

15.6.4. UK
15.6.4.1. UK Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.4.2. UK Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.4.3. UK Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.4.4. UK Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.4.5. UK Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.4.6. UK Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
15.6.5. Italy
15.6.5.1. Italy Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.5.2. Italy Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.5.3. Italy Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.5.4. Italy Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.5.5. Italy Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.5.6. Italy Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
15.6.6. Spain
15.6.6.1. Spain Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.6.2. Spain Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.6.3. Spain Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.6.4. Spain Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.6.5. Spain Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.6.6. Spain Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

15.6.7. Rest of Europe
15.6.7.1. Rest of Europe Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.6.7.2. Rest of Europe Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
15.6.7.3. Rest of Europe Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
15.6.7.4. Rest of Europe Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
15.6.7.5. Rest of Europe Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
15.6.7.6. Rest of Europe Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

16. Asia Pacific Radiopharmaceutical theranostics Market Analysis
16.1. Asia Pacific Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Asia Pacific Radiopharmaceutical theranostics Market, by Source, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Asia Pacific Radiopharmaceutical theranostics Market, by Approach, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Asia Pacific Radiopharmaceutical theranostics Market, by End-User, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Asia Pacific Radiopharmaceutical theranostics Market, by Application, 2017-2030(US$ Bn)
16.5.1. Overview
16.5.2. SRC Analysis

16.6. Asia Pacific Radiopharmaceutical theranostics Market, by Country, 2017-2030 (US$ Bn)
16.6.1. Asia Pacific Radiopharmaceutical theranostics Market, by Country, 2022 Vs 2030 (in%)
16.6.2. China
16.6.2.1. China Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.2.2. China Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.2.3. China Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.2.4. China Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.2.5. China Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
16.6.2.6. China Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
16.6.3. Japan
16.6.3.1. Japan Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.3.2. Japan Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.3.3. Japan Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.3.4. Japan Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.3.5. Japan Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
16.6.3.6. Japan Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

16.6.4. India
16.6.4.1. India Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.4.2. India Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.4.3. India Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.4.4. India Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.4.5. India Radiopharmaceutical theranostics Market, By End-Users, 2017-2030 (US$ Bn)
16.6.4.6. India Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

16.6.5. South Korea
16.6.5.1. South Korea Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.5.2. South Korea Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.5.3. South Korea Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.5.4. South Korea Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.5.5. South Korea Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
16.6.5.6. South Korea Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

16.6.6. South-East Asia
16.6.6.1. South-East Asia Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.6.2. South-East Asia Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.6.3. South-East Asia Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.6.4. South-East Asia Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.6.5. South-East Asia Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
16.6.6.6. South-East Asia Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

16.6.7. Rest of Asia Pacific
16.6.7.1. Rest of Asia Pacific Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.6.7.2. Rest of Asia Pacific Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
16.6.7.3. Rest of Asia Pacific Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
16.6.7.4. Rest of Asia Pacific Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
16.6.7.5. Rest of Asia Pacific Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
16.6.7.6. Rest of Asia Pacific Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

17. Latin America Radiopharmaceutical theranostics Market Analysis
17.1. Latin America Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2030(US$ Bn)
17.1.1. Overview
17.1.2. SRC Analysis
17.2. Latin America Radiopharmaceutical theranostics Market, by Source, 2017-2030(US$ Bn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Latin America Radiopharmaceutical theranostics Market, by Approach, 2017-2030(US$ Bn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Latin America Radiopharmaceutical theranostics Market, by End-User, 2017-2030(US$ Bn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Latin America Radiopharmaceutical theranostics Market, by Application, 2017-2030(US$ Bn)
17.5.1. Overview
17.5.2. SRC Analysis

17.6. Latin America Radiopharmaceutical theranostics Market, by Country, 2017-2030 (US$ Bn)
17.6.1. Latin America Radiopharmaceutical theranostics Market, by Country, 2022 Vs 2030 (in%)
17.6.2. Brazil
17.6.2.1. Brazil Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.6.2.2. Brazil Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
17.6.2.3. Brazil Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
17.6.2.4. Brazil Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
17.6.2.5. Brazil Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
17.6.2.6. Brazil Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

17.6.3. Argentina
17.6.3.1. Argentina Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.6.3.2. Argentina Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
17.6.3.3. Argentina Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
17.6.3.4. Argentina Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
17.6.3.5. Argentina Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
17.6.3.6. Argentina Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

17.6.4. Rest of Latin America
17.6.4.1. Rest of Latin America Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.6.4.2. Rest of Latin America Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
17.6.4.3. Rest of Latin America Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
17.6.4.4. Rest of Latin America Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
17.6.4.5. Rest of Latin America Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
17.6.4.6. Rest of Latin America Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

18. Middle East and Africa Radiopharmaceutical theranostics Market Analysis
18.1. Middle East and Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2030(US$ Bn)
18.1.1. Overview
18.1.2. SRC Analysis
18.2. Middle East and Africa Radiopharmaceutical theranostics Market, by Source, 2017-2030(US$ Bn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Middle East and Africa Radiopharmaceutical theranostics Market, by Approach, 2017-2030(US$ Bn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Middle East and Africa Radiopharmaceutical theranostics Market, by End-User, 2017-2030(US$ Bn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Middle East and Africa Radiopharmaceutical theranostics Market, by Application, 2017-2030(US$ Bn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Middle East and Africa Radiopharmaceutical theranostics Market, by Country, 2017-2030 (US$ Bn)
18.6.1. Middle East and Africa Radiopharmaceutical theranostics Market, by Country, 2022 Vs 2030 (in%)
18.6.2. GCC Countries
18.6.2.1. GCC Countries Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.6.2.2. GCC Countries Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
18.6.2.3. GCC Countries Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
18.6.2.4. GCC Countries Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
18.6.2.5. GCC Countries Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
18.6.2.6. GCC Countries Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)
18.6.3. South Africa
18.6.3.1. South Africa Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.6.3.2. South Africa Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
18.6.3.3. South Africa Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
18.6.3.4. South Africa Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
18.6.3.5. South Africa Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
18.6.3.6. South Africa Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

18.6.4. Rest of Middle East and Africa
18.6.4.1. Rest of Middle East and Africa Radiopharmaceutical theranostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.6.4.2. Rest of Middle East and Africa Radiopharmaceutical theranostics Market, By Radiosotope, 2017-2030 (US$ Bn)
18.6.4.3. Rest of Middle East and Africa Radiopharmaceutical theranostics Market, By Source, 2017-2030 (US$ Bn)
18.6.4.4. Rest of Middle East and Africa Radiopharmaceutical theranostics Market, By Approach, 2017-2030 (US$ Bn)
18.6.4.5. Rest of Middle East and Africa Radiopharmaceutical theranostics Market, By End-User, 2017-2030 (US$ Bn)
18.6.4.6. Rest of Middle East and Africa Radiopharmaceutical theranostics Market, By Application, 2017-2030 (US$ Bn)

19. Company Profiles
19.1. Bayer AG
19.1.1. Company Overview
19.1.2. Products/Services Portfolio
19.1.3. Geographical Presence
19.1.4. Financial Summary
19.1.4.1. Market Revenue and Net Profit (2019-2022)
19.1.4.2. Business Segment Revenue Analysis
19.1.4.3. Geographical Revenue Analysis
19.2. GE HealthCare Technologies Inc
19.3. Curium
19.4. Lantheus Medical Imaging, Inc.
19.5. Telix Pharmaceuticals Ltd.
19.6. Cardinal Health Inc
19.7. Advanced Accelerator Applications S.A.
19.8. Jubilant Radiopharma
19.9. Theragnostics
19.10. NuView Life Sciences

List of Figures
FIG. 1 Global Radiopharmaceutical theranostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Radiopharmaceutical theranostics Market Segmentation
FIG. 4 Global Radiopharmaceutical theranostics Market, by Radiosotope, 2022 (US$ Bn)
FIG. 5 Global Radiopharmaceutical theranostics Market, by Source, 2022 (US$ Bn)
FIG. 6 Global Radiopharmaceutical theranostics Market, by Approach, 2022 (US$ Bn)
FIG. 7 Global Radiopharmaceutical theranostics Market, by End-User, 2022 (US$ Bn)
FIG. 8 Global Radiopharmaceutical theranostics Market, by Application, 2022 (US$ Bn)
FIG. 9 Global Radiopharmaceutical theranostics Market, by Geography, 2022 (US$ Bn)
FIG. 10 Attractive Investment Proposition, by Radiosotope, 2022
FIG. 11 Attractive Investment Proposition, by Source, 2022
FIG. 12 Attractive Investment Proposition, by Approach, 2022
FIG. 13 Attractive Investment Proposition, by End-User, 2022
FIG. 14 Attractive Investment Proposition, by Application, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Radiopharmaceutical theranostics Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Radiopharmaceutical theranostics Market Manufacturers, 2022
FIG. 18 Global Radiopharmaceutical theranostics Market Value Contribution, By Radiosotope, 2022 & 2030 (Value %)
FIG. 19 Global Radiopharmaceutical theranostics Market, by Targeted Therapeutic (Rx), Value, 2017-2030 (US$ Bn)
FIG. 20 Global Radiopharmaceutical theranostics Market, by Companion Diagnostic (DX), Value, 2017-2030 (US$ Bn)
FIG. 21 Global Radiopharmaceutical theranostics Market, by Radiotracer Type, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Radiopharmaceutical theranostics Market, by Peptidic, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Radiopharmaceutical theranostics Market, by Non-peptidic, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Radiopharmaceutical theranostics Market Value Contribution, By Source, 2022 & 2030 (Value %)
FIG. 25 Global Radiopharmaceutical theranostics Market, by Nuclear Reactors, 2017-2030 (US$ Bn)
FIG. 26 Global Radiopharmaceutical theranostics Market, by Cyclotrons, 2017-2030 (US$ Bn)
FIG. 27 Global Radiopharmaceutical theranostics Market Value Contribution, By Approach, 2022 & 2030 (Value %)
FIG. 28 Global Radiopharmaceutical theranostics Market, by Oncology, 2017-2030 (US$ Bn)
FIG. 29 Global Radiopharmaceutical theranostics Market, by Cardiology, 2017-2030 (US$ Bn)
FIG. 30 Global Radiopharmaceutical theranostics Market, by others, 2017-2030 (US$ Bn)
FIG. 31 Global Radiopharmaceutical theranostics Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 32 Global Radiopharmaceutical theranostics Market, by Hospitals, 2017-2030 (US$ Bn)
FIG. 33 Global Radiopharmaceutical theranostics Market, by Academic & Research Institutes, 2017-2030 (US$ Bn)
FIG. 34 Global Radiopharmaceutical theranostics Market, by Others, 2017-2030 (US$ Bn)
FIG. 35 Global Radiopharmaceutical theranostics Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 36 Global Radiopharmaceutical theranostics Market, by Technetium-99, Value, 2017-2030 (US$ Bn)
FIG. 37 Global Radiopharmaceutical theranostics Market, by Iodine-131, 2017-2030 (US$ Bn)
FIG. 38 Global Radiopharmaceutical theranostics Market, by Gallium-68, 2017-2030 (US$ Bn)
FIG. 39 Global Radiopharmaceutical theranostics Market, by Radium-223, 2017-2030 (US$ Bn)
FIG. 40 Global Radiopharmaceutical theranostics Market, by Fluorine-18, 2017-2030 (US$ Bn)
FIG. 41 Global Radiopharmaceutical theranostics Market, by Lutetium-177, 2017-2030 (US$ Bn)
FIG. 42 Global Radiopharmaceutical theranostics Market, by Yttrium-90, 2017-2030 (US$ Bn)
FIG. 43 Global Radiopharmaceutical theranostics Market, by Copper-67 & 64, 2017-2030 (US$ Bn)
FIG. 44 Global Radiopharmaceutical theranostics Market, by Samarium- 153-90, 2017-2030 (US$ Bn)
FIG. 45 Global Radiopharmaceutical theranostics Market, by Others, 2017-2030 (US$ Bn)
FIG. 46 North America Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 47 U.S. Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 48 Canada Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 49 Europe Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 50 Germany Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 51 France Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 52 U.K. Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 53 Italy Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 54 Spain Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 55 Rest of Europe Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 56 Asia Pacific Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 57 China Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 58 Japan Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 59 India Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 60 South Korea Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 61 South-East Asia Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 62 Rest of Asia Pacific Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 63 Latin America Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 64 Brazil Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 65 Mexico Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 66 Rest of Latin America Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 67 Middle East & Africa Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 68 GCC Countries Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 69 South Africa Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)
FIG. 70 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Radiopharmaceutical theranostics Market
TABLE 2 Global Radiopharmaceutical theranostics Market: Market Drivers Impact Analysis
TABLE 3 Global Radiopharmaceutical theranostics Market: Market Restraints Impact Analysis
TABLE 4 Global Radiopharmaceutical theranostics Market, by Competitive Benchmarking, 2022
TABLE 5 Global Radiopharmaceutical theranostics Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Radiopharmaceutical theranostics Market, by Key Strategies Analysis, 2022
TABLE 7 Global Radiopharmaceutical theranostics Market, by Targeted Therapeutic (Rx), By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Radiopharmaceutical theranostics Market, by Targeted Therapeutic (Rx), By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Radiopharmaceutical theranostics Market, by Companion Diagnostic (DX), By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Radiopharmaceutical theranostics Market, by Companion Diagnostic (DX), By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Radiopharmaceutical theranostics Market, by Radiotracer Type, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Radiopharmaceutical theranostics Market, by Radiotracer Type, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Radiopharmaceutical theranostics Market, by Peptidic, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Radiopharmaceutical theranostics Market, by Peptidic, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Radiopharmaceutical theranostics Market, by Non-peptidic, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Radiopharmaceutical theranostics Market, by Non-peptidic, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Radiopharmaceutical theranostics Market, by Nuclear Reactors, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Radiopharmaceutical theranostics Market, by Nuclear Reactors, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Radiopharmaceutical theranostics Market, by Cyclotrons, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Radiopharmaceutical theranostics Market, by Cyclotrons, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Radiopharmaceutical theranostics Market, by Oncology, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Radiopharmaceutical theranostics Market, by Oncology, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Radiopharmaceutical theranostics Market, by Cardiology, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Radiopharmaceutical theranostics Market, by Cardiology, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Radiopharmaceutical theranostics Market, by others, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Radiopharmaceutical theranostics Market, by others, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Radiopharmaceutical theranostics Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Radiopharmaceutical theranostics Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Radiopharmaceutical theranostics Market, by Academic & Research Institutes, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Radiopharmaceutical theranostics Market, by Academic & Research Institutes, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Radiopharmaceutical theranostics Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Radiopharmaceutical theranostics Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Radiopharmaceutical theranostics Market, by Technetium-99, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Radiopharmaceutical theranostics Market, by Technetium-99, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Radiopharmaceutical theranostics Market, by Gallium-68, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Radiopharmaceutical theranostics Market, by Gallium-68, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Radiopharmaceutical theranostics Market, by Iodine-131, By Region, 2017-2022 (US$ Bn)
TABLE 38 Global Radiopharmaceutical theranostics Market, by Iodine-131, By Region, 2023-2030 (US$ Bn)
TABLE 39 Global Radiopharmaceutical theranostics Market, by Radium-223, By Region, 2017-2022 (US$ Bn)
TABLE 40 Global Radiopharmaceutical theranostics Market, by Radium-223, By Region, 2023-2030 (US$ Bn)
TABLE 41 Global Radiopharmaceutical theranostics Market, by Fluorine-18, By Region, 2017-2022 (US$ Bn)
TABLE 42 Global Radiopharmaceutical theranostics Market, by Fluorine-18, By Region, 2023-2030 (US$ Bn)
TABLE 43 Global Radiopharmaceutical theranostics Market, by Yttrium-90, By Region, 2017-2022 (US$ Bn)
TABLE 44 Global Radiopharmaceutical theranostics Market, by Yttrium-90, By Region, 2023-2030 (US$ Bn)
TABLE 45 Global Radiopharmaceutical theranostics Market, by Lutetium-177, By Region, 2017-2022 (US$ Bn)
TABLE 46 Global Radiopharmaceutical theranostics Market, by Lutetium-177, By Region, 2023-2030 (US$ Bn)
TABLE 47 Global Radiopharmaceutical theranostics Market, Copper-67 & 64, By Region, 2017-2022 (US$ Bn)
TABLE 48 Global Radiopharmaceutical theranostics Market, by Copper-67 & 64, By Region, 2023-2030 (US$ Bn)
TABLE 49 Global Radiopharmaceutical theranostics Market, by Samarium- 153, By Region, 2017-2022 (US$ Bn)
TABLE 50 Global Radiopharmaceutical theranostics Market, by Samarium- 153, By Region, 2023-2030 (US$ Bn)
TABLE 51 Global Radiopharmaceutical theranostics Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 52 Global Radiopharmaceutical theranostics Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 53 Global Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 54 Global Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 55 Global Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 56 Global Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 57 Global Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 58 Global Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 59 Global Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 60 Global Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 61 Global Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 62 Global Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 63 Global Radiopharmaceutical theranostics Market, by Region, 2017-2022 (US$ Bn)
TABLE 64 Global Radiopharmaceutical theranostics Market, by Region, 2023-2030 (US$ Bn)
TABLE 65 North America Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 66 North America Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 67 North America Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 68 North America Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 69 North America Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 70 North America Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 71 North America Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 72 North America Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 73 North America Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 74 North America Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 75 North America Radiopharmaceutical theranostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 76 North America Radiopharmaceutical theranostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 77 United States Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 78 United States Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 79 United States Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 80 United States Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 81 United States Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 82 United States Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 83 United States Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 84 United States Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 85 United States Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 86 United States Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 87 Canada Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 88 Canada Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 89 Canada Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 90 Canada Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 91 Canada Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 92 Canada Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 93 Canada Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 94 Canada Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 95 Canada Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 96 Canada Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 97 Mexico Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 98 Mexico Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 99 Mexico Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 100 Mexico Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 101 Mexico Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 102 Mexico Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 103 Mexico Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 104 Mexico Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 105 Mexico Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 106 Mexico Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 107 Europe Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 108 Europe Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 109 Europe Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 110 Europe Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 111 Europe Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 112 Europe Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 113 Europe Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 114 Europe Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 115 Europe Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 116 Europe Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 117 Europe Radiopharmaceutical theranostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 118 Europe Radiopharmaceutical theranostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 119 Germany Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 120 Germany Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 121 Germany Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 122 Germany Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 123 Germany Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 124 Germany Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 125 Germany Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 126 Germany Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 127 Germany Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 128 Germany Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 129 France Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 130 France Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 131 France Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 132 France Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 133 France Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 134 France Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 135 France Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 136 France Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 137 France Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 138 France Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 139 United Kingdom Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 140 United Kingdom Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 141 United Kingdom Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 142 United Kingdom Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 143 United Kingdom Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 144 United Kingdom Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 145 United Kingdom Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 146 United Kingdom Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 147 United Kingdom Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 148 United Kingdom Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 149 Italy Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 150 Italy Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 151 Italy Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 152 Italy Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 153 Italy Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 154 Italy Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 155 Italy Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 156 Italy Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 157 Italy Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 158 Italy Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 159 Spain Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 160 Spain Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 161 Spain Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 162 Spain Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 163 Spain Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 164 Spain Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 165 Spain Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 166 Spain Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 167 Spain Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 168 Spain Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 169 Rest of Europe Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 170 Rest of Europe Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 171 Rest of Europe Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 172 Rest of Europe Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 173 Rest of Europe Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 174 Rest of Europe Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 175 Rest of Europe Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 176 Rest of Europe Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 177 Rest of Europe Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 178 Rest of Europe Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 179 Asia Pacific Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 180 Asia Pacific Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 181 Asia Pacific Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 182 Asia Pacific Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 183 Asia Pacific Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 184 Asia Pacific Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 185 Asia Pacific Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 186 Asia Pacific Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 187 Asia Pacific Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 188 Asia Pacific Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 189 Asia Pacific Radiopharmaceutical theranostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 190 Asia Pacific Radiopharmaceutical theranostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 191 China Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 192 China Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 193 China Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 194 China Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 195 China Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 196 China Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 197 China Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 198 China Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 199 China Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 200 China Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 201 Japan Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 202 Japan Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 203 Japan Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 204 Japan Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 205 Japan Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 206 Japan Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 207 Japan Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 208 Japan Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 209 Japan Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 210 Japan Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 211 Bn)
TABLE 212 India Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 213 India Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 214 India Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 215 India Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 216 India Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 217 India Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 218 India Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 219 India Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 220 India Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 221 India Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 222 South Korea Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 223 South Korea Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 224 South Korea Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 225 South Korea Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 226 South Korea Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 227 South Korea Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 228 South Korea Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 229 South Korea Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 230 South Korea Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 231 South Korea Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 232 South-East Asia Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 233 South-East Asia Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 234 South-East Asia Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 235 South-East Asia Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 236 South-East Asia Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 237 South-East Asia Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 238 South-East Asia Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 239 South-East Asia Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 240 South-East Asia Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 241 South-East Asia Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 242 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 243 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 244 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 245 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 246 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 247 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 248 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 249 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 250 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 251 Rest of Asia Pacific Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 252 Latin America Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 253 Latin America Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 254 Latin America Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 255 Latin America Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 256 Latin America Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 257 Latin America Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 258 Latin America Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 259 Latin America Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 260 Latin America Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 261 Latin America Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 262 Latin America Radiopharmaceutical theranostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 263 Latin America Radiopharmaceutical theranostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 264 Brazil Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 265 Brazil Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 266 Brazil Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 267 Brazil Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 268 Brazil Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 269 Brazil Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 270 Brazil Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 271 Brazil Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 272 Brazil Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 273 Brazil Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 274 Argentina Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 275 Argentina Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 276 Argentina Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 277 Argentina Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 278 Argentina Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 279 Argentina Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 280 Argentina Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 281 Argentina Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 282 Argentina Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 283 Argentina Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 284 Rest of Latin America Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 285 Rest of Latin America Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 286 Rest of Latin America Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 287 Rest of Latin America Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 288 Rest of Latin America Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 289 Rest of Latin America Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)

TABLE 290 Rest of Latin America Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 291 Rest of Latin America Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 292 Rest of Latin America Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 293 Rest of Latin America Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 294 Middle East and Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 295 Middle East and Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 296 Middle East and Africa Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 297 Middle East and Africa Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 298 Middle East and Africa Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 299 Middle East and Africa Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 300 Middle East and Africa Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 301 Middle East and Africa Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 302 Middle East and Africa Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 303 Middle East and Africa Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 304 GCC Countries Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 305 GCC Countries Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 306 GCC Countries Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 307 GCC Countries Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 308 GCC Countries Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 309 GCC Countries Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 310 GCC Countries Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 311 GCC Countries Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 312 GCC Countries Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 313 GCC Countries Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 314 South Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 315 South Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 316 South Africa Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 317 South Africa Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 318 South Africa Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 319 South Africa Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 320 South Africa Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 321 South Africa Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 322 South Africa Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 323 South Africa Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 324 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2017-2022 (US$ Bn)
TABLE 325 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Radiosotope, 2023-2030 (US$ Bn)
TABLE 326 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Source, 2017-2022 (US$ Bn)
TABLE 327 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Source, 2023-2030 (US$ Bn)
TABLE 328 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Approach, 2017-2022 (US$ Bn)
TABLE 329 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Approach, 2023-2030 (US$ Bn)
TABLE 330 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by End-User, 2017-2022 (US$ Bn)
TABLE 331 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 332 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 333 Rest of Middle East and Africa Radiopharmaceutical theranostics Market, by Application, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of The Radiopharmaceutical Theranostics Market?

The Radiopharmaceutical Theranostics Market was valued at USD 1.6 billion in 2022.

What is the expected growth rate of The Radiopharmaceutical Theranostics Market between 2023 and 2030?

The Radiopharmaceutical Theranostics Market  is expected to grow at a CAGR of 11.90% between 2023 and 2030, reaching USD 3.52 billion in 2030.

Which segment is leading the market share in terms of source?

Cyclotron is the leading segment in source types, holding a significant share in terms of value.

Which region is fuelling the growth of The Radiopharmaceutical Theranostics Market?

North America region is fuelling the growth of The Radiopharmaceutical Theranostics Market , with a significant share in 2022.

Who are the major players in the Radiopharmaceutical Theranostics Market?

The top players include Bayer AG, GE HealthCare Technologies Inc, Curium, Lantheus Medical Imaging, Inc., Telix Pharmaceuticals Ltd., Cardinal Health Inc, Advanced Accelerator Applications S.A., Jubilant Radiopharma, Theragnostics, NuView Life Sciences

What are the major market drivers of The Radiopharmaceutical Theranostics Market?

Generating major oncology deals globally and the rise in incidence and prevalence of target conditions are the major drivers of market growth.

What are the major market restraints of The Radiopharmaceutical Theranostics Market?

Short half-life of radiopharmaceuticals and high equipment prices is the major market restraints.

What are the major market opportunities of The Radiopharmaceutical Theranostics Market?

The rise in initiatives to reduce the demand-supply gap offers a significant growth opportunity for Radiopharmaceutical Theranostics Market.

What are the leading approach types of The Radiopharmaceutical Theranostics Market?

Targeted therapeutics are leading the market in terms of approach.

What segment is leading the market growth in terms of application?

Oncology  is leading the market growth in terms of application.

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Precision Medicine Market

Published:
Report ID: 11123

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN